Author/Authors :
Rimsevicius, Laurynas Faculty of Medicine - Vilnius University, Vilnius, Lithuania , Sukackiene, Diana Faculty of Medicine - Vilnius University, Vilnius, Lithuania , Tamulyte, Giedre Faculty of Medicine - Vilnius University, Vilnius, Lithuania , Kirkilaite, Greta Faculty of Medicine - Vilnius University, Vilnius, Lithuania , Miglinas, Marius Faculty of Medicine - Vilnius University, Vilnius, Lithuania
Abstract :
Psoriasis vulgaris is not frequently seen in patients with renal
replacement therapy, especially in patients on peritoneal dialysis.
Dialysis also has been reported to improve psoriatic skin lesions
with a much higher response rate for peritoneal dialysis than
haemodialysis. Conversely, we present a case of a man who developed
psoriasis after 16 months of peritoneal dialysis. Discontinuation of
icodextrin as a possible factor provoking systemic inflammation
had no impact on the course of the disease. In this report, we
review the existing studies and counsel caution against optimistic
expectations of benefits from dialysis in patients with psoriasis.